Literature DB >> 33549867

Transient Elastography-Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States.

Aynur Unalp-Arida1, Constance E Ruhl2.   

Abstract

BACKGROUND & AIMS: We examined transient elastography assessed hepatic steatosis and fibrosis distributions and relationships with body composition in a representative United States population sample.
METHODS: Liver stiffness and controlled attenuation parameter (CAP) were assessed on 4870 non-Hispanic White, non-Hispanic Black, non-Hispanic Asian, and Hispanic men and women aged 20 years and over in the National Health and Nutrition Examination Survey (NHANES) 2017-2018. Participants underwent anthropometry and dual-energy x-ray absorptiometry (DXA).
RESULTS: Compared to women, men had higher mean CAP (274.2 dB/m vs 254.4 dB/m) and liver stiffness (6.4 kPa vs 5.5 kPa). CAP and liver stiffness increased through middle age and markedly with BMI. In multivariate-adjusted analysis, CAP in the upper quartile was associated with increased age, BMI, waist-to-hip ratio, diabetes, hypertension, alanine aminotransferase (ALT) and C-reactive protein and decreased HDL cholesterol. After adjustment, non-Hispanic Blacks had lower CAP and non-Hispanic Asians had higher CAP. In multivariate-adjusted analysis, liver stiffness in the upper quartile was associated with male sex, increased age, BMI, diabetes, hepatitis C virus positivity, ALT and CAP. Lower stiffness among Non-Hispanic Asians was not significant after adjustment for BMI. DXA trunk and extremity fat mass were positively related to both CAP and liver stiffness with multivariate adjustment (P < .001 for each). Results were similar with CAP and liver stiffness as continuous characteristics.
CONCLUSIONS: In the United States population, increased anthropometric and DXA body composition measures were associated with higher CAP and liver stiffness. Racial-ethnic differences observed merit further research to elucidate the burden of obesity and liver health disparities. Published by Elsevier Inc.

Entities:  

Keywords:  Controlled Attenuation Parameter; Dual-Energy X-Ray Absorptiometry; Fatty Liver Disease; Liver Stiffness; National Health and Nutrition Examination Survey

Mesh:

Year:  2021        PMID: 33549867     DOI: 10.1016/j.cgh.2021.02.009

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  6 in total

1.  Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease.

Authors:  Diana Barb; Enrico M Repetto; Michael E Stokes; Sudha S Shankar; Kenneth Cusi
Journal:  Obesity (Silver Spring)       Date:  2021-09-23       Impact factor: 9.298

2.  Sugar-sweetened Beverages Are Associated With Increased Liver Stiffness and Steatosis Among Apparently Healthy Adults in the United States.

Authors:  Cindy W Leung; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2021-05-28       Impact factor: 11.382

3.  Associations between alcohol consumption and hepatic steatosis in the USA.

Authors:  Sebastian Niezen; Hirsh D Trivedi; Kenneth J Mukamal; Zhenghui G Jiang
Journal:  Liver Int       Date:  2021-08-05       Impact factor: 8.754

4.  The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.

Authors:  Naim Alkhouri; Ashraf Almomani; Phuc Le; Julia Y Payne; Imad Asaad; Celine Sakkal; Miriam Vos; Mazen Noureddin; Prabhat Kumar
Journal:  BMC Gastroenterol       Date:  2022-07-30       Impact factor: 2.847

5.  Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Dig Dis Sci       Date:  2022-09-29       Impact factor: 3.487

6.  Prevalence of High Liver Stiffness and a Screening Strategy Using the SODA-2B Score Among US Adults.

Authors:  Sebastian Niezen; Elliot B Tapper; Hirsh Trivedi; Michelle Lai; Michael P Curry; Kenneth J Mukamal; Z Gordon Jiang
Journal:  Hepatol Commun       Date:  2021-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.